Product Information

TUSSIN CF MAX SEVERE M-S COLD is a generic product labeled by Cardinal Health, priced at $0.0241 per ML under NDC 70000062301. Its NADAC has been published 101 times since Sep 18, 2024.

OTC

Strength

650; 20; 400; 10 mg/20mL; mg/20mL; mg/20mL; mg/20mL

Manufacturer

Cardinal Health

NDC

70000062301

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

5/20/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

1/31/2023

Pharmacological Classes

Adrenergic alpha1-Agonists
Decreased Respiratory Secretion Viscosity
Expectorant
Increased Respiratory Secretions
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for TUSSIN CF MAX SEVERE M-S COLD has been published 101 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0241 per ML
All-time high$0.0251 (Aug 13, 2025)
All-time low$0.0230 (Jan 21, 2026)
52-week high$0.0248
52-week low$0.0230
Median price$0.0241
Average price$0.0240
Largest weekly change+3.5% (Jun 18, 2025)
Weeks tracked101
Tracking sinceSep 18, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+3.1%

1Y

-2.8%

3Y

N/A

5Y

N/A

All

+0.3%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of TUSSIN CF MAX SEVERE M-S COLD?

The current National Average Drug Acquisition Cost (NADAC) for TUSSIN CF MAX SEVERE M-S COLD, manufactured by Cardinal Health, is $0.0241 per ML (NDC 70000062301), effective Aug 19, 2026.

How has the price of TUSSIN CF MAX SEVERE M-S COLD changed over time?

Over the history we have for it, the NADAC for TUSSIN CF MAX SEVERE M-S COLD has held within roughly two percent of its current level. It has been tracked across 101 weekly CMS publications since Sep 18, 2024.

What are the highest and lowest recorded NADAC prices for TUSSIN CF MAX SEVERE M-S COLD?

Since Sep 18, 2024, the NADAC for TUSSIN CF MAX SEVERE M-S COLD has ranged from a low of $0.0230 (Jan 21, 2026) to a high of $0.0251 (Aug 13, 2025), with a median of $0.0241 per ML.

Are there cheaper alternatives to TUSSIN CF MAX SEVERE M-S COLD?

No other NADAC-published product currently shares the active ingredient and strength of TUSSIN CF MAX SEVERE M-S COLD in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TUSSIN CF MAX SEVERE M-S COLD?

TUSSIN CF MAX SEVERE M-S COLD (NDC 70000062301) is labeled by Cardinal Health, and CMS classifies it as a generic product.